DRESS syndrome following ciprofloxacin exposure: An unusual association

被引:12
作者
Alkhateeb, Haider [1 ]
Said, Sarmad [1 ]
Cooper, Chad J. [1 ]
Gaur, Sumit [1 ,2 ]
Porres-Aguilar, Mateo [1 ]
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Internal Med, El Paso, TX 79409 USA
[2] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Div Hematol Oncol, El Paso, TX USA
关键词
DRESS syndrome; eosinophilia; ciprofloxacin;
D O I
10.12659/AJCR.889703
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Drug Reaction with Eosinophilia and Systemic Symptoms ( DRESS) is a rare, potentially life-threatening drug reaction with a mean latency period of 3.9 weeks. It has been described in association with many medications; yet, Ciprofloxacin was reported once in literature to be the offending drug. We are presenting a rare case of Ciprofloxacin-induced DRESS syndrome with symptom onset 2 days after exposure. Case Report: A 24-year-old female presented with symptoms suggestive of UTI and was prescribed Ciprofloxacin. Two days later she started to complain of fever, diffuse rash, swelling of her face, arms and flanks, watery diarrhea and muscular pain. Five days after symptom onset she presented to our institution with WBC count 38,810 cells/mu L and absolute Eosinophil count 17,080 cell/mu L. Peripheral blood smear showed immature Eosinophilic myelocytes and metamyelocytes. Skin biopsy showed superficial perivascular lymphocytic infiltration with dermal edema. Further workup was negative for parasitic infestations, HIV and viral hepatitis, allergic diseases, hematologic and non-hematologic malignancies, vasculitides and autoimmune processes. Ciprofloxacin was discontinued upon admission and the patient started to improve quickly. Patient was followed in clinic after 3 weeks and was completely asymptomatic with WBC count 7,250 cell/mu L and absolute Eosinophil count 2,900 cell/mu L. Conclusions: DRESS syndrome is a possible complication of Ciprofloxacin treatment that clinicians should consider. Shorter latency period might be a unique feature of Fluoroquinolone- induced DRESS syndrome. According to RegiSCAR scoring system, our case is categorized as (probable) with a score of (4). In fact, the vast majority of reported cases are classified as (probable/definite).
引用
收藏
页码:526 / 528
页数:3
相关论文
共 6 条
[1]  
Artukovic M, 2010, ACTA CLIN CROAT, V49, P479
[2]   Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS) [J].
Bocquet, H ;
Bagot, M ;
Roujeau, JC .
SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 1996, 15 (04) :250-257
[3]   The DRESS Syndrome: A Literature Review [J].
Cacoub, Patrice ;
Musette, Philippe ;
Descamps, Vincent ;
Meyer, Olivier ;
Speirs, Chris ;
Finzi, Laetitia ;
Roujeau, Jean Claude .
AMERICAN JOURNAL OF MEDICINE, 2011, 124 (07) :588-597
[4]   A 6-month prospective survey of cutaneous drug reactions in a hospital setting [J].
Fiszenson-Albala, F ;
Auzerie, V ;
Mahe, E ;
Farinotti, R ;
Durand-Stocco, C ;
Crickx, B ;
Descamps, V .
BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (05) :1018-1022
[5]  
Husain Z, 2013, J AM ACAD DERMATOL, V68, P706, DOI DOI 10.1016/J.JAAD.2013.01.033
[6]   Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? [J].
Kardaun, S. H. ;
Sidoroff, A. ;
Valeyrie-Allanore, L. ;
Halevy, S. ;
Davidovici, B. B. ;
Mockenhaupt, M. ;
Roujeau, J. C. .
BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (03) :609-611